Advertisement
<< Back To Article
Microbicide Success Story: What It Means and Where We Go Next

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

7 Comments

mietwagen mallorca

I had been arguing with my close friend on this issue for quite a while, base on your ideas prove that I am right, let me show him your webpage then I am sure it must make him buy me a drink, lol, thanks. - Kris

October 17, 2010 Hamburg

maria

WHEN WILL THE GEL BE AVAILABLE TO THE MARKET

September 1, 2010 SOUTH AFRICA

Marco Portillo

Its coming "vivagel" is the one in the next 2 years... Let's all hope of the pharmaceutical and condom companies let this product hit the market!!! On 3 humans clinical trials "vivagel" protects up to 95% from hiv and hsv... Lets make it boyss.. google it

July 31, 2010 nyc

Susan

And I still ahve the same old question...when, oh when, will they studies that can benefit us gals who are HIV+ and want to keep our male partners safe?

July 23, 2010 Boston, MA

Jack

I was happy to read about the recent success in Africa with this gel procedure in women. I am wondering if it would be possible to develop the same procedure for men and women to use anally. Would the gel have the same effect of attacking HIV cells in the anal canal of men and women? If not, what would be the reason it would not work. It would seem that the anal canal would be much like the vaginal canal, when receiving the gel and killing HIV Cells in sperm.

July 22, 2010 San Diego

Travis

Did not state if there were any skin reactions to the male in the study. Also didn't state if this agent kills Sperm. We need answers.

July 22, 2010 Modesto

Brian

If the blood levels of the drug are linked to the efficacy, then why are we using a gel as a drug delivery tool? Why not just use a pill? This would be an off-label use, but the drug is already approved in pill form. The most obvious use is for hiv negative partners in relationships with HIV positive people as a backup protection method for preventing infection. It begs the question- Can monotherapy be a successful prophylactic?

July 22, 2010 Houston, TX

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.